Newly characterized molecule offers possibilities for novel Alzheimer’s treatments

A study by researchers investigated lesser-known molecules involved in tauopathies like Alzheimer’s. They focused on microRNAs (miRNAs), gene expression regulators that bind to and destroy protein-encoding messenger RNAs. They discovered that some of these miRNAs showed neuroprotective effects; their supplementation therefore holds potential as a treatment for tauopathies.

Source: sciencedaily.com

Related posts

Genetics, not lack of oxygen, causes cerebral palsy in quarter of cases

Origin of Roman lead

Researchers use foundation models to discover new cancer imaging biomarkers